Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland

AJ Palmer; S Roze; WJ Valentine; JA Ray

doi:10.57187/smw.2006.11337

Original article

Vol. 136 No. 2122 (2006)

Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland

AJ Palmer
S Roze
WJ Valentine
JA Ray

Fulltext PDF

Cite this as:: Swiss Med Wkly. 2006;136:346-346
Published: 27.05.2006

How to Cite

1.

Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland. Swiss Med Wkly [Internet]. 2006 May 27 [cited 2025 Nov. 4];136(2122):346-. Available from: https://smw.ch/index.php/smw/article/view/611

Share

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

DOI:: https://doi.org/10.57187/smw.2006.11337